{"result": "(\"entity\"<|>DUGGAN C<|>PERSON<|>Duggan C is a co-author of the study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>DOLAN M<|>PERSON<|>Dolan M is a co-author of the study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>ARIAGNO K<|>PERSON<|>Ariagno K is a co-author of the study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>JIANG H<|>PERSON<|>Jiang H is a co-author of the study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>DUGGAN C<|>PERSON<|>Duggan C is a co-author of the study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>HARDY G<|>PERSON<|>Hardy G is a co-author of a paper on compounding all-in-one parenteral nutrition admixtures.)\n##\n(\"entity\"<|>BALL P<|>PERSON<|>Ball P is a co-author of a paper on compounding all-in-one parenteral nutrition admixtures.)\n##\n(\"entity\"<|>MCELROY B<|>PERSON<|>McElroy B is a co-author of a paper on compounding all-in-one parenteral nutrition admixtures.)\n##\n(\"entity\"<|>HOJSAK I<|>PERSON<|>Hojsak I is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.)\n##\n(\"entity\"<|>BRAEGGER C<|>PERSON<|>Braegger C is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.)\n##\n(\"entity\"<|>BRONSKY J<|>PERSON<|>Bronsky J is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.)\n##\n(\"entity\"<|>CAMPLOY C<|>PERSON<|>Campoy C is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.)\n##\n(\"entity\"<|>DOMELLÖF M<|>PERSON<|>Domellöf M is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.)\n##\n(\"entity\"<|>CALKINS KL<|>PERSON<|>Calkins KL is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>DUNN JCY<|>PERSON<|>Dunn JCY is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>SHEW SB<|>PERSON<|>Shew SB is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>REYEN L<|>PERSON<|>Reyen L is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>FARMER DG<|>PERSON<|>Farmer DG is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>DEVASKAR SU<|>PERSON<|>Devaskar SU is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>VENICK RS<|>PERSON<|>Venick RS is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>FISHBEIN TM<|>PERSON<|>Fishbein TM is a co-author of a study on hepatic explant pathology of pediatric intestinal transplant recipients.)\n##\n(\"entity\"<|>HYPERGLYCEMIA AND OUTCOME IN THE PEDIATRIC INTENSIVE CARE UNIT<|>EVENT<|>The study on hyperglycemia and outcome in the pediatric intensive care unit discusses the effects of hyperglycemia on critically ill children.)\n##\n(\"entity\"<|>PEDIATRIC CRITICAL ILLNESS HYPERGLYCEMIA<|>EVENT<|>The study on pediatric critical illness hyperglycemia discusses risk factors associated with hyperglycemia in critically ill children.)\n##\n(\"relationship\"<|>DUGGAN C<|>MEHTA NM<|>Duggan C and Mehta NM co-authored a study on energy imbalance in critically ill children<|>8)\n##\n(\"relationship\"<|>DOLAN M<|>MEHTA NM<|>Dolan M and Mehta NM co-authored a study on energy imbalance in critically ill children<|>8)\n##\n(\"relationship\"<|>ARIAGNO K<|>MEHTA NM<|>Ariagno K and Mehta NM co-authored a study on energy imbalance in critically ill children<|>8)\n##\n(\"relationship\"<|>JIANG H<|>MEHTA NM<|>Jiang H and Mehta NM co-authored a study on energy imbalance in critically ill children<|>8)\n##\n(\"relationship\"<|>HARDY G<|>NUTR CLIN PRACT<|>Hardy G's paper on compounding all-in-one parenteral nutrition admixtures was published in Nutrition Clinical Practice<|>7)\n##\n(\"relationship\"<|>BALL P<|>NUTR CLIN PRACT<|>Ball P's paper on compounding all-in-one parenteral nutrition admixtures was published in Nutrition Clinical Practice<|>7)\n##\n(\"relationship\"<|>MCELROY B<|>NUTR CLIN PRACT<|>McElroy B's paper on compounding all-in-one parenteral nutrition admixtures was published in Nutrition Clinical Practice<|>7)\n##\n(\"relationship\"<|>HOJSAK I<|>J PEDIATR GASTROENTEROL NUTR<|>Hojsak I's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>BRAEGGER C<|>J PEDIATR GASTROENTEROL NUTR<|>Braegger C's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>BRONSKY J<|>J PEDIATR GASTROENTEROL NUTR<|>Bronsky J's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>CAMPLOY C<|>J PEDIATR GASTROENTEROL NUTR<|>Campoy C's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>DOMELLÖF M<|>J PEDIATR GASTROENTEROL NUTR<|>Domellöf M's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>CALKINS KL<|>J PEDIATR GASTROENTEROL NUTR<|>Calkins KL's study on pediatric intestinal failure was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>FISHBEIN TM<|>J PEDIATR<|>Fishbein TM's study on hepatic explant pathology was published in Journal of Pediatric<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Suárez L, eds. Manual práctico de nutrición en pediatría, 1.ª ed. Madrid: Ergon, 2007; 1-11.\n15. Moráis López A, Lama More RA, Galera Martínez R. Consejos prácticos para la prescripción de nutrición parenteral pediátrica. Acta Pediatr Esp. 2016; 74(2): 57-63.\n---\nTema 55. Nutrición parenteral en el paciente pediátrico: vías y fórmulas 877\n\n16. Mehta NM, Bechard LJ, Dolan M, Ariagno K, Jiang H, Duggan C.Energy imbalance and the risk of overfeeding in critically ill children.Pediatr Crit Care Med. 2011; 12(4):398-405.\n\n17. Schofield W. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985; 39C S1; 5-41.\n\n18. Krenitsky J. Adjusted body weight, pro: evidence to support the use of adjusted body weight in calculating calorie requirements. Nutr Clin Pract. 2005; 20:468-73.\n\n19. Challenges to nutrition therapy in the pediatric critically ill obese patient. Martinez EE, Ariagno K, Arriola A, Lara K, Mehta NM. Nutr Clin Pract. 2015; 30: 432-9.\n\n20. Jesuit C, Dillon C, Compher C, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors; and Lenders CM. A.S.P.E.N. clinical guidelines: Nutrition support of hospitalized pediatric patients with obesity. JPEN J Parenter Enteral Nutr. 2010; 34(1):13-20.\n\n21. Lacaille F, Gupte G, Colomb V, D'Antiga L, Hartman C, Hojsak I, et al. Intestinal failure-associated liver disease: a position paper of the ESPGHAN working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015; 60: 272-83.\n\n22. Klein GW, Hojsak JM, Schmeidler J, Rapaport R.Hyperglycemia and outcome in the pediatric intensive care unit. J Pediatr. 2008; 153:379-84.\n\n23. Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr. 2009; 155:734-9.\n\n24. Rigo J, De Curtis M. Parenteral nutrition in premature infants. En: Guandalini S, ed. Textbook of Pediatric Gastroenterology and Nutrition. London: Taylor and Francis; 2004. p. 619-38.\n\n25. Hardy G, Ball P, McElroy B. Basic principles for compounding all-in-one parenteral nutrition admixtures . Curr Opin Clin Nutr Metab Care. 1998; 1: 291-296.\n\n26. Hojsak I, Colomb V, Braegger C, Bronsky J, Campoy C, Domellöf M, et al. ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis. J Pediatr Gastroenterol Nutr. 2016; 62:776-92.\n\n27. Cowan E, Nandivada P, Puder M. Fish oil-based lipid emulsion in the treatment ofparenteral nutrition-associated liver disease. Curr Opin Pediatr. 2013; 25:193–200.\n\n28. Calkins KL, Dunn JCY, Shew SB, Reyen L, Farmer DG, Devaskar SU, Venick RS. Pediatric intestinal failure associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enteral Nutr. 2014; 38(6):682-92.\n\n29. Matsumoto CS, Kaufman SS, Island ER, Kallakury B, Yazigi NA, Khan KM, Fishbein TM. Hepatic explant pathology of pediatric intestinal transplant recipients previously treated with omega-3 fatty acid lipid emulsion. J Pediatr. 2014; 165(1):59-64.\n\n30. Mercer DF, Hobson BD, Fischer RT, Talmon GA, Perry DA, Gerhardt BK, et al. Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion. J Pediatr Gastroenterol Nutr. 2013; 56(4):364-9.\n\n31. Poindexter BB, Ehrenkranz RA. In: Martin RJ, Faranoff AA, Walsh MC. Faranoff and Martin's Neonatal Perinatal Medicine. Diseases of the fetus and infant. Philadephia: Elsevier Saunders; 2015. p. 592-612.\n\n32. Uthaya S, Modi N. Practical preterm parenteral nutrition: systematic literature review and recommedations for practice. Early Hum Dev. 2014; 90:747-53.\n\n33. Uthaya S, Liu X, Babalis D, Doré CJ, Warwick J, Bell J, et al. Nutritional evaluation and optimisation in neonates:\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SUÁREZ L<|>PERSON<|>Suárez L is the editor of the practical manual on pediatric nutrition published in Madrid by Ergon in 2007.)\n##\n(\"entity\"<|>ERGO<|>ORGANIZATION<|>Ergon is the publishing house that released the manual on pediatric nutrition.)\n##\n(\"entity\"<|>MADRIGAL<|>GEO<|>Madrid is the capital of Spain where the manual on pediatric nutrition was published.)\n##\n(\"entity\"<|>MORAÍS LÓPEZ A<|>PERSON<|>Moráis López A is an author of practical advice for the prescription of pediatric parenteral nutrition.)\n##\n(\"entity\"<|>LAMA MORE RA<|>PERSON<|>Lama More RA is a co-author of the practical advice for pediatric parenteral nutrition.)\n##\n(\"entity\"<|>GALERA MARTÍNEZ R<|>PERSON<|>Galera Martínez R is another co-author of the practical advice for pediatric parenteral nutrition.)\n##\n(\"entity\"<|>ACTA PEDIATR ESP<|>ORGANIZATION<|>Acta Pediatr Esp is the journal where the practical advice for pediatric parenteral nutrition was published in 2016.)\n##\n(\"entity\"<|>MEHTA NM<|>PERSON<|>Mehta NM is an author of a study on energy imbalance and the risk of overfeeding in critically ill children.)\n##\n(\"entity\"<|>BECHARD LJ<|>PERSON<|>Bechard LJ is a co-author of the study on energy imbalance in critically ill children.)\n##\n(\"entity\"<|>DOLAN M<|>PERSON<|>Dolan M is a co-author of the study on energy imbalance in critically ill children.)\n##\n(\"entity\"<|>ARIAGNO K<|>PERSON<|>Ariagno K is a co-author of the study on energy imbalance in critically ill children.)\n##\n(\"entity\"<|>JIANG H<|>PERSON<|>Jiang H is a co-author of the study on energy imbalance in critically ill children.)\n##\n(\"entity\"<|>DUGGAN C<|>PERSON<|>Duggan C is a co-author of the study on energy imbalance in critically ill children.)\n##\n(\"entity\"<|>HUM NUTR CLIN NUTR<|>ORGANIZATION<|>Human Nutrition Clinical Nutrition is the journal where the study on predicting basal metabolic rate was published.)\n##\n(\"entity\"<|>SCHOFIELD W<|>PERSON<|>Schofield W is the author of a study on predicting basal metabolic rate.)\n##\n(\"entity\"<|>KRENITSKY J<|>PERSON<|>Krenitsky J is the author of a paper supporting the use of adjusted body weight in calculating calorie requirements.)\n##\n(\"entity\"<|>NUTR CLIN PRACT<|>ORGANIZATION<|>Nutrition Clinical Practice is the journal where the paper on challenges to nutrition therapy in pediatric critically ill obese patients was published.)\n##\n(\"entity\"<|>MARTINEZ EE<|>PERSON<|>Martinez EE is a co-author of the paper on challenges to nutrition therapy in pediatric critically ill obese patients.)\n##\n(\"entity\"<|>LARA K<|>PERSON<|>Lara K is a co-author of the paper on challenges to nutrition therapy in pediatric critically ill obese patients.)\n##\n(\"entity\"<|>JESUIT C<|>PERSON<|>Jesuit C is a co-author of the A.S.P.E.N. clinical guidelines on nutrition support of hospitalized pediatric patients with obesity.)\n##\n(\"entity\"<|>A.S.P.E.N.<|>ORGANIZATION<|>The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is the organization that published clinical guidelines on nutrition support for hospitalized pediatric patients.)\n##\n(\"entity\"<|>LENDERS CM<|>PERSON<|>Lenders CM is a co-author of the A.S.P.E.N. clinical guidelines on nutrition support of hospitalized pediatric patients with obesity.)\n##\n(\"entity\"<|>ESPGHAN<|>ORGANIZATION<|>The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) is the organization that published a position paper on intestinal failure-associated liver disease.)\n##\n(\"entity\"<|>HOJSAK I<|>PERSON<|>Hojsak I is a co-author of the position paper on intestinal failure-associated liver disease.)\n##\n(\"entity\"<|>J PEDIATR GASTROENTEROL NUTR<|>ORGANIZATION<|>Journal of Pediatric Gastroenterology and Nutrition is the journal where the position paper on intestinal failure-associated liver disease was published.)\n##\n(\"entity\"<|>KLEIN GW<|>PERSON<|>Klein GW is the author of a study on hyperglycemia and outcome in the pediatric intensive care unit.)\n##\n(\"entity\"<|>PREISSIG CM<|>PERSON<|>Preissig CM is the author of a study on pediatric critical illness hyperglycemia.)\n##\n(\"entity\"<|>RIGO J<|>PERSON<|>Rigo J is a co-author of a chapter on parenteral nutrition in premature infants.)\n##\n(\"entity\"<|>GUANDALINI S<|>PERSON<|>Guandalini S is the editor of the textbook of Pediatric Gastroenterology and Nutrition.)\n##\n(\"entity\"<|>TAYLOR AND FRANCIS<|>ORGANIZATION<|>Taylor and Francis is the publishing house for the textbook of Pediatric Gastroenterology and Nutrition.)\n##\n(\"entity\"<|>CALKINS KL<|>PERSON<|>Calkins KL is a co-author of a study on pediatric intestinal failure associated liver disease.)\n##\n(\"entity\"<|>MATSUMOTO CS<|>PERSON<|>Matsumoto CS is a co-author of a study on hepatic explant pathology of pediatric intestinal transplant recipients.)\n##\n(\"entity\"<|>MERCER DF<|>PERSON<|>Mercer DF is a co-author of a study on hepatic fibrosis in children treated with intravenous fish oil emulsion.)\n##\n(\"entity\"<|>POINDEXTER BB<|>PERSON<|>Poindexter BB is a co-author of a chapter in Faranoff and Martin's Neonatal Perinatal Medicine.)\n##\n(\"entity\"<|>MARTIN RJ<|>PERSON<|>Martin RJ is a co-author of a chapter in Faranoff and Martin's Neonatal Perinatal Medicine.)\n##\n(\"entity\"<|>FARANOFF AA<|>PERSON<|>Faranoff AA is a co-author of a chapter in Faranoff and Martin's Neonatal Perinatal Medicine.)\n##\n(\"entity\"<|>WALSH MC<|>PERSON<|>Walsh MC is a co-author of a chapter in Faranoff and Martin's Neonatal Perinatal Medicine.)\n##\n(\"entity\"<|>UTHAYA S<|>PERSON<|>Uthaya S is a co-author of a systematic literature review on practical preterm parenteral nutrition.)\n##\n(\"entity\"<|>NUTRITIONAL EVALUATION AND OPTIMISATION IN NEONATES<|>EVENT<|>Nutritional evaluation and optimization in neonates is a topic discussed in the literature.)\n##\n(\"relationship\"<|>SUÁREZ L<|>ERGO<|>Suárez L edited the manual on pediatric nutrition published by Ergon<|>8)\n##\n(\"relationship\"<|>MORAÍS LÓPEZ A<|>ACTA PEDIATR ESP<|>Moráis López A's work on pediatric parenteral nutrition was published in Acta Pediatr Esp<|>7)\n##\n(\"relationship\"<|>LAMA MORE RA<|>ACTA PEDIATR ESP<|>Lama More RA's work on pediatric parenteral nutrition was published in Acta Pediatr Esp<|>7)\n##\n(\"relationship\"<|>GALERA MARTÍNEZ R<|>ACTA PEDIATR ESP<|>Galera Martínez R's work on pediatric parenteral nutrition was published in Acta Pediatr Esp<|>7)\n##\n(\"relationship\"<|>MEHTA NM<|>HUM NUTR CLIN NUTR<|>Mehta NM's study on energy imbalance was published in Human Nutrition Clinical Nutrition<|>7)\n##\n(\"relationship\"<|>SCHOFIELD W<|>HUM NUTR CLIN NUTR<|>Schofield W's study on basal metabolic rate was published in Human Nutrition Clinical Nutrition<|>7)\n##\n(\"relationship\"<|>KRENITSKY J<|>NUTR CLIN PRACT<|>Krenitsky J's paper on adjusted body weight was published in Nutrition Clinical Practice<|>7)\n##\n(\"relationship\"<|>MARTINEZ EE<|>NUTR CLIN PRACT<|>Martinez EE's paper on nutrition therapy was published in Nutrition Clinical Practice<|>7)\n##\n(\"relationship\"<|>JESUIT C<|>A.S.P.E.N.<|>Jesuit C contributed to the A.S.P.E.N. clinical guidelines<|>8)\n##\n(\"relationship\"<|>HOJSAK I<|>ESPGHAN<|>Hojsak I contributed to the position paper published by ESPGHAN<|>8)\n##\n(\"relationship\"<|>KLEIN GW<|>J PEDIATR<|>Klein GW's study on hyperglycemia was published in Journal of Pediatric<|>7)\n##\n(\"relationship\"<|>PREISSIG CM<|>J PEDIATR<|>Preissig CM's study on hyperglycemia was published in Journal of Pediatric<|>7)\n##\n(\"relationship\"<|>RIGO J<|>TAYLOR AND FRANCIS<|>Rigo J's chapter on parenteral nutrition was published in a textbook by Taylor and Francis<|>8)\n##\n(\"relationship\"<|>CALKINS KL<|>J PEDIATR GASTROENTEROL NUTR<|>Calkins KL's study on pediatric intestinal failure was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>MATSUMOTO CS<|>J PEDIATR<|>Matsumoto CS's study on hepatic explant pathology was published in Journal of Pediatric<|>7)\n##\n(\"relationship\"<|>MERCER DF<|>J PEDIATR GASTROENTEROL NUTR<|>Mercer DF's study on hepatic fibrosis was published in Journal of Pediatric Gastroenterology and Nutrition<|>7)\n##\n(\"relationship\"<|>POINDEXTER BB<|>FARANOFF AA<|>Poindexter BB and Faranoff AA co-authored a chapter in Faranoff and Martin's Neonatal Perinatal Medicine<|>9)\n##\n(\"relationship\"<|>MARTIN RJ<|>FARANOFF AA<|>Martin RJ and Faranoff AA co-authored a chapter in Faranoff and Martin's Neonatal Perinatal Medicine<|>9)\n##\n(\"relationship\"<|>UTHAYA S<|>NUTRITIONAL EVALUATION AND OPTIMISATION IN NEONATES<|>Uthaya S's work on preterm parenteral nutrition relates to nutritional evaluation in neonates<|>6)\n<|COMPLETE|>"}]}